CoChat

Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera

Open access

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

In β-thalassemia and polycythemia vera (PV), disordered erythropoiesis triggers severe pathophysiological manifestations. β-Thalassemia is characterized by ineffective erythropoiesis, reduced production of erythrocytes, anemia, and iron overload and PV by erythrocytosis and thrombosis. Minihepcidins are hepcidin agonists that have been previously shown to prevent iron overload in murine models of hemochromatosis and induce iron-restricted erythropoiesis at higher doses. Here, we show that in young Hbb(th3/+) mice, which serve as a model of untransfused β-thalassemia, minihepcidin ameliorates ineffective erythropoiesis, anemia, and iron overload. In older mice with untransfused β-thalassemia, minihepcidin improves erythropoiesis and does not alter the beneficial effect of the iron chelator deferiprone on iron overload. In PV mice that express the orthologous JAK2 mutation causing human PV, administration of minihepcidin significantly reduces splenomegaly and normalizes hematocrit levels. These studies indicate that drug-like minihepcidins have a potential as future therapeutics for untransfused β-thalassemia and PV.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2015-10-676742

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Cited by

See all 148

Metadata

Authors
Casu, C., Oikonomidou, P. R., Chen, H., Nandi, V., Ginzburg, Y., Prasad, P., Fleming, R. E., Shah, Y. M., Valore, E. V., Nemeth, E., Ganz, T., MacDonald, B., & Rivella, S.
Affiliations
  • Children's Hospital of Philadelphia (US)
  • Erythropoiesis Laboratory, and
  • New York Blood Center (US)
  • Department of Pediatrics, and
  • Saint Louis University (US)
  • University of Michigan (US)
  • Department of Medicine, and
  • University of California, Los Angeles (US)
  • Merganser Biotech Inc., King of Prussia, PA;
Venue
Blood
Published
2016-07-14
Volume
128
Issue
2
Pages
265-276
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2401643476
Cited by
148
References
28
Citations by year
2026: 7 · 2025: 10 · 2024: 9 · 2023: 13 · 2022: 13 · 2021: 23 · 2020: 19 · 2019: 18 · 2018: 17 · 2017: 17 · 2016: 2
FWCI
17.11
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Heart, Lung, and Blood Institute (K08HL105682)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK090554, R01DK107309, R01DK095201, R01DK095112, R01DK107670)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
  • Health Sciences › Medicine › Hematology › Myeloproliferative Neoplasms: Diagnosis and Treatment
Keywords
beta-thalassemia, polycythemia vera, iron overload, ineffective erythropoiesis, anemia, deferiprone, JAK2 mutation, splenomegaly, disease modifiers, iron chelation
MeSH terms
Animals, Erythropoiesis, Mice, Mutant Strains, Peptides, Polycythemia Vera, beta-Thalassemia, Amino Acid Substitution, Mutation, Missense, Mice, Janus Kinase 2, Hepcidins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera. https://app.cochat.ai/papers/10.1182/blood-2015-10-676742
The paper
Casu, C., Oikonomidou, P. R., Chen, H., Nandi, V., Ginzburg, Y., Prasad, P., Fleming, R. E., Shah, Y. M., Valore, E. V., Nemeth, E., Ganz, T., MacDonald, B., & Rivella, S. (2016). Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera. Blood. https://doi.org/10.1182/blood-2015-10-676742

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.